Works matching IS 0008543X AND DT 2023 AND VI 129 AND IP 24


Results: 22
    1
    2
    3
    4
    6
    7

    A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
    By:
    • Bairey, Osnat;
    • Taliansky, Alisa;
    • Glik, Amir;
    • Amiel, Alexandra;
    • Yust‐Katz, Shlomit;
    • Gurion, Ronit;
    • Zektser, Miri;
    • Porges, Tzvika;
    • Sarid, Nadav;
    • Horowitz, Netanel A.;
    • Shina, Tzahala Tzuk;
    • Lebel, Eyal;
    • Cohen, Amos;
    • Geiger, Karyn Revital;
    • Raanani, Pia;
    • Wolach, Ofir;
    • Siegal, Tali
    Publication type:
    Article
    9
    10
    11
    12
    13

    Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3884, doi. 10.1002/cncr.34982
    By:
    • Nazha, Bassel;
    • Zhuang, Tony;
    • Wu, Sharon;
    • Brown, Jacqueline T.;
    • Magee, Daniel;
    • Carthon, Bradley C.;
    • Kucuk, Omer;
    • Nabhan, Chadi;
    • Barata, Pedro C.;
    • Heath, Elisabeth I.;
    • Ryan, Charles J.;
    • McKay, Rana R.;
    • Master, Viraj A.;
    • Bilen, Mehmet Asim
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Issue Information.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3833, doi. 10.1002/cncr.33739
    Publication type:
    Article